Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127666521 | 12766652 | 1 | I | 20160914 | 20160914 | 20160921 | 20160921 | EXP | IT-JNJFOC-20160914716 | JANSSEN | 41.00 | YR | A | F | Y | 0.00000 | 20160921 | CN | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127666521 | 12766652 | 1 | PS | TOPAMAX | TOPIRAMATE | 1 | Oral | U | U | 20505 | 50 | MG | TABLETS | ||||||
| 127666521 | 12766652 | 2 | SS | VALIUM | DIAZEPAM | 1 | Oral | U | 0 | DROPS |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127666521 | 12766652 | 1 | Product used for unknown indication |
| 127666521 | 12766652 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127666521 | 12766652 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127666521 | 12766652 | Intentional overdose | |
| 127666521 | 12766652 | Intentional self-injury | |
| 127666521 | 12766652 | Sluggishness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127666521 | 12766652 | 1 | 20160914 | 20160914 | 0 | |
| 127666521 | 12766652 | 2 | 20160914 | 20160914 | 0 |